CAN
FLNA

Cetera Advisor Networks’s Filana Therapeutics FLNA Stock Holding History

Cetera Advisor Networks’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$369K Buy
18,180
+3,105
+21% +$71.5K ﹤0.01% 2135
2023
Q4 		$339K Buy
15,075
+4,208
+39% +$88.9K ﹤0.01% 2156
2023
Q3 		$181K Buy
+10,867
New +$215K ﹤0.01% 2461
2022
Q4 		– Sell
-31,871
Closed -$1.33M – 2588
2022
Q3 		$1.33M Buy
31,871
+20,141
+172% +$544K 0.02% 749
2022
Q2 		$330K Sell
11,730
-13,242
-53% -$334K ﹤0.01% 1561
2022
Q1 		$927K Buy
24,972
+2,817
+13% +$119K 0.01% 957
2021
Q4 		$968K Buy
22,155
+4,060
+22% +$213K 0.01% 922
2021
Q3 		$1.12M Buy
18,095
+8,048
+80% +$672K 0.02% 794
2021
Q2 		$858K Buy
10,047
+532
+6% +$28.5K 0.01% 888
2021
Q1 		$428K Sell
9,515
-23,145
-71% -$910K 0.01% 953
2020
Q4 		$223K Buy
32,660
+16,200
+98% +$145K 0.01% 1202
2020
Q3 		$189K Buy
16,460
+2,460
+18% +$11.1K ﹤0.01% 1145
2020
Q2 		$43K Buy
14,000
+500
+4% +$2.27K ﹤0.01% 1995
2020
Q1 		$55K Sell
13,500
-7,500
-36% -$49.7K ﹤0.01% 1084
2019
Q4 		$109K Buy
+21,000
New +$36.3K ﹤0.01% 1203

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cetera Advisor Networks's FLNA Position: Q1 2024 in Review

Cetera Advisor Networks increased its Filana Therapeutics (FLNA) stake by 21% in Q1 2024, buying an estimated $71.5K and bringing the position to 18,180 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

Cetera Advisor Networks first reported a position in FLNA in Q4 2019 and has held it in 15 quarters since. The position peaked at $1.33M in Q3 2022. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

  • Cetera Advisor Networks held 18,180 shares of Filana Therapeutics worth $369K as of Q1 2024.
  • Cetera Advisor Networks bought 3,105 Filana Therapeutics shares in Q1 2024, an estimated $71.5K.
  • Filana Therapeutics made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2135 holding.
  • Cetera Advisor Networks first reported a position in Filana Therapeutics in Q4 2019 and has held it in 15 quarters since.
  • Cetera Advisor Networks's Filana Therapeutics position peaked at $1.33M in Q3 2022.
  • 143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.